why choose us

First received: September 20, 2023

Clinical Trial: Reducing Frailty for Older Cancer Survivors Using Supplements II

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Frailty

Study Type: INTERVENTIONAL


Official Title: A Phase 2 Randomized Controlled Trial of Epigallocatechin-3-Gallate (EGCG) on Frailty and Inflammation in Older Survivors of Cancer

Brief Summary: This study is a two-arm placebo controlled randomized clinical trial, to assess the effect of a 12-week EGCG intervention on physical frailty compared to placebo in pre-frail older cancer survivors.

Read more